Yongxiang Zheng serves as Executive at NovaBay Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Yongxiang Zheng has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 11, 2023 involved exercising options for 858 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 11, 2023 | NBY | $0 | Option Exercise | 858 | $N/A | Discretionary |
Yongxiang Zheng currently holds 858 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yongxiang Zheng has been a net neutral trader of NBY stock. They have purchased $0 and sold $0 worth of shares.
Yongxiang Zheng's most recent insider trade was on May 11, 2023, when they sold 858 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted